You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Moodys
Medtronic
Boehringer Ingelheim
McKesson

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

Litigation Details for APOTEX INC. v. FOOD AND DRUG ADMINISTRATION (D.C. 2006)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in APOTEX INC. v. FOOD AND DRUG ADMINISTRATION
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for APOTEX INC. v. FOOD AND DRUG ADMINISTRATION (D.C. 2006)

Date Filed Document No. Description Snippet Link To Document
2006-11-06 1 Complaint including: U.S. Patent No. 4,695,578 (“the ‘578 patent”), which has expired; U.S. Patent No. 5,578,628 …Book-listed patent for the NDA drug: (l) that there is no patent information; (II) that the listed patent has …5,578,628 (“the ‘628 patent), which has expired; U.S. Patent No. 4,753,789 (“the ‘789 patent), which has expired…the listed patent, a so-called “paragraph III certification”; or (IV) that the listed patent is invalid… any ANDA applicant in any patent infringement case involving the patent-at-issue. Thus, the first generic External link to document
2006-11-17 12 relevant patents in the Orange Book with respect to its drug; U.S. Patent Nos, 4,346,227 ("the…relevant patents in the Orange Book with respect to its drug: U.S. Patent i+los. 4;346,227 ("…`658 patent, and alleging that the ` 658 patent is not infringed and/or that the patent is invalid… the `658 patent, and alleging that the `658 patent is not infringed and/or that the patent is invalid….S. Patent NV. Patent -r J ("the '658 patent"), entitled External link to document
2006-11-17 13 Memorandum in Opposition on any patent that claims the drug or a method of using the drug and for which a claim of patent infringement… to such patent has not been filed; (II) that such patent has expired; …that such patent will expire on a particular date; or (IV) that such patent is invalid…has not been filed with FDA or the patent has expired, then the patent, by itself, will not delay approval… applicable patent has expired, and FDA will not approve the ANDA until after the patent has expired. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKinsey
Boehringer Ingelheim
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.